Publications by authors named "Alice Conner"

Claim this Profile
[
[F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study.
David L Chan, Aimee Hayes, Ioannis Karfis, Alice Conner, Magdalena Mileva

J Nucl Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]FMISO PET in metastatic neuroendocrine tumours: a pilot study.
David L Chan, Alice Conner, Nick Pavlakis, Elizabeth Bailey, Alireza Aslani

Asia Ocean J Nucl Med Biol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Tumor Volume on 18-Fluorodeoxyglucose Positron Emission Tomography as a Prognostic Marker of Survival in Patients With Locally Advanced or Metastatic Neuroendocrine Neoplasms Treated With 177Lutetium-DOTA-Octreotate Peptide Receptor Radionuclide Therapy.
Madhawa K De Silva, David L H Chan, Elizabeth J Bernard, Alice J Conner, Sophie L Mascall

Pancreas· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]FDG PET/CT-Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study.
David L Chan, Aimee R Hayes, Ioannis Karfis, Alice Conner, Magdalena Mileva

J Nucl Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual [Ga]DOTATATE and [F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score.
David L Chan, Aimee R Hayes, Ioannis Karfis, Alice Conner, Luke Furtado O'Mahony

Br J Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis